Portfolio company
Peloton Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops small molecule oral medicines for patients with renal cell carcinoma and other forms of cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
Accent Therapeutics
This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.
Apexian Pharmaceuticals
This company develops oral small molecule drugs targeting specific proteins to treat patients with cancer and inflammatory bowel diseases.
Scorpion Therapeutics
This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.
Iterion Therapeutic
This biopharmaceutical company develops small molecule inhibitors for patients with Wnt-driven cancers, including hepatocellular carcinoma and colorectal cancer.
1200 Pharma
This biotechnology firm develops small molecule therapies and drug intellectual property for the treatment of cancer patients.
BlossomHill Therapeutics
This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.
Nuvectis Pharma
This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.